BRPI0515443A - combinação de poliquitosamina e de inibidor de hmg-coa reductase para hiperlipidemia - Google Patents

combinação de poliquitosamina e de inibidor de hmg-coa reductase para hiperlipidemia

Info

Publication number
BRPI0515443A
BRPI0515443A BRPI0515443-0A BRPI0515443A BRPI0515443A BR PI0515443 A BRPI0515443 A BR PI0515443A BR PI0515443 A BRPI0515443 A BR PI0515443A BR PI0515443 A BRPI0515443 A BR PI0515443A
Authority
BR
Brazil
Prior art keywords
frequency
channel
digital
audio
stereo
Prior art date
Application number
BRPI0515443-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Andre Aube
Jean-Guy Lehoux
Ryszard Brzezinski
Gilles Dupuis
Original Assignee
Dnp Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dnp Canada Inc filed Critical Dnp Canada Inc
Publication of BRPI0515443A publication Critical patent/BRPI0515443A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Stereo-Broadcasting Methods (AREA)
BRPI0515443-0A 2004-09-15 2005-09-14 combinação de poliquitosamina e de inibidor de hmg-coa reductase para hiperlipidemia BRPI0515443A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60983004P 2004-09-15 2004-09-15
PCT/CA2005/001406 WO2006029524A1 (en) 2004-09-15 2005-09-14 Combination of polychitosamine and hmg-coa reductase inhibitor for hyperlipidemia

Publications (1)

Publication Number Publication Date
BRPI0515443A true BRPI0515443A (pt) 2008-07-29

Family

ID=36059676

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0515443-0A BRPI0515443A (pt) 2004-09-15 2005-09-14 combinação de poliquitosamina e de inibidor de hmg-coa reductase para hiperlipidemia

Country Status (8)

Country Link
US (5) US20060058261A1 (enExample)
EP (1) EP1812019A4 (enExample)
JP (1) JP2008513379A (enExample)
CN (1) CN101052405A (enExample)
AU (1) AU2005284565A1 (enExample)
BR (1) BRPI0515443A (enExample)
CA (1) CA2580460A1 (enExample)
WO (1) WO2006029524A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207646B1 (en) * 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US20080182819A1 (en) * 2007-01-29 2008-07-31 Act Iii Licensing, Llc Chitosan compositions and methods for using chitosan compositions in the treatment of health disorders
CN105859639A (zh) 2009-03-18 2016-08-17 雷斯韦洛吉克斯公司 新的抗炎剂
CA2758172C (en) 2009-04-08 2019-01-15 Nanyang Polytechnic A plant extract comprising statins and preparation techniques and uses thereof
CA2869821C (en) 2011-06-13 2018-06-19 Rival, Societe En Commandite N,n,n-trialkylaminopolymers, methods of their preparation and uses thereof
EP4371866A3 (en) * 2018-09-26 2024-07-17 TQ-Systems GmbH Method and device for dynamically controlling a range of an electrically-assisted bicycle, electrically-assisted bicycle
IT201900021291A1 (it) * 2019-11-15 2021-05-15 Biomedica Pharma Gmbh Chitosano e prodotto medicale per l’uso in un metodo di prevenzione o trattamento di una malattia cardiovascolare

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903140A (en) * 1970-09-08 1975-09-02 Alza Corp Diazadodecane prostaglandin compounds
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
DK149080C (da) * 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
DE69319921T2 (de) * 1992-12-01 1999-04-15 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Dauerhafte antimikrobische mittel
FI107432B (fi) * 1997-02-06 2001-08-15 Novasso Oy Mikrokiteisen kitosaanin käyttö
FI982291L (fi) * 1998-10-23 2000-04-24 Novasso Oy Aine kolesterolin sekä lipidien pitoisuuden alentamiseksi
US20020016307A1 (en) * 1999-10-27 2002-02-07 Mullins John Jason Gentry Pharmaceutical composition with both a lipase inhibitor and a lipophilic polysaccharide and an improved method for treating adiposity
US6933291B2 (en) * 2000-12-01 2005-08-23 N.V. Nutricia Cholesterol lowering supplement
KR20040026705A (ko) * 2001-08-16 2004-03-31 테바 파마슈티컬 인더스트리즈 리미티드 스타틴의 칼슘 염 형태의 제조 방법
GB0302738D0 (en) * 2003-02-06 2003-03-12 Advanced Biopolymers As Composition

Also Published As

Publication number Publication date
US20120258932A1 (en) 2012-10-11
AU2005284565A1 (en) 2006-03-23
CN101052405A (zh) 2007-10-10
US20130244973A1 (en) 2013-09-19
US20060058261A1 (en) 2006-03-16
EP1812019A1 (en) 2007-08-01
WO2006029524A1 (en) 2006-03-23
US20110028429A1 (en) 2011-02-03
JP2008513379A (ja) 2008-05-01
US20090197830A1 (en) 2009-08-06
CA2580460A1 (en) 2006-03-23
EP1812019A4 (en) 2007-12-26

Similar Documents

Publication Publication Date Title
WO2006084916A3 (en) Parametric joint-coding of audio sources
EP1523132B8 (en) Digital transmission of audio signals
IL177379A0 (en) Transmission of signaling information for broadcast and multicast services
WO2008110003A8 (en) A universal television receiver
WO2009100246A3 (en) Systems, methods, and devices for scanning broadcasts
AU2002240800A1 (en) Electroacoustic conversion of audio signals, especially voice signals
WO2003032148A8 (en) Datacast distribution system
EP2172015A4 (en) DIGITAL BROADCASTING SYSTEM AND METHOD OF PROCESSING DATA
AU2002322503A1 (en) Digital audio/video broadcast on cellular systems
WO2008157549A3 (en) Apparatus and methods of enhancing radio programming
EP1616424A4 (en) MULTICHANNEL QUADRATURE AMPLITUDE MODULATION WITH WIDE BAND OF CABLE TELEVISION SIGNALS
BRPI0515443A (pt) combinação de poliquitosamina e de inibidor de hmg-coa reductase para hiperlipidemia
GB0229781D0 (en) Secure transmission of audio signals
TW200623878A (en) Direct digital encoding and radio frequency modulation for broadcast television application
CN104410946A (zh) 一种无线多设备组合实现多声道输出音频的方法及系统
DE69901546D1 (de) Universelles signalverteilsystem
WO2006020376A3 (en) Method of transmitting audio and video signals overs radio and television channels
ECSP034457A (es) Codificador vsb de bajo costo y modulador fr para suministrar una señal sustancial vsb de 6 mhz a un receptor digital de television
MX2007008932A (es) Peliculas doblables de poliolefina.
AU2003299204A1 (en) Focal calcium channel modulation
GB0307448D0 (en) Modulated output of digital audio signals
RU2006144618A (ru) Способ передачи цифровой информации в звуковых каналах радиовещания и телефонных каналах
UA49416A (uk) Спосіб передачі програм звукового супроводження телевізійного сигналу
AU4422300A (en) Robust coding for the transmission of audio or video signals
IT1306116B1 (it) Modulatore tv stereo/bifonico per la distribuzione di segnali video/audio

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.